chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Sinusitis, Somnolence
Clinical narrative: very sick; In bed sleeping for 2-3 days.; Mega cold like symptoms; Mega cold like symptoms that started with sinus infection.; Very tired for over 7 days; Restless sleep at night; Lots of mucus; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) in the left arm on 15Apr2021 at 11:00 (at the age of 35-year-old) as a dose for COVID-19 immunisation. The patient did not have any relevant medical history. Concomitant medication taken within two weeks of vaccination was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 17Apr2021 at 11:00, the patient was very sick, in bed sleeping for 2-3 days, mega cold like symptoms that started with sinus infection, very tired for over 7 days, restless sleep at night and lots of mucus. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events very sick, in bed sleeping, mega cold like symptoms that started with sinus infection, very tired, restless sleep at night and lots of mucus was resolved with sequelae at the time of this report.    No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Heart rate, Heart rate increased, Myalgia, Pain in extremity
Clinical narrative: High fever; Heart beat constantly over 115/min; Muscle ache; Arm pain; Belly pain; Red dots on skin; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 06May2021 at 18:00 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history included dust allergy and allergy to oyster (seafood allergy). Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. On 06May2021 at 23:00, the patient experienced high fever, heart beat constantly over 115/min, muscle ache, arm pain, belly pain and red dots on skin. The events resulted in emergency room/department or urgent care. Therapeutic measures were taken as a result of the events (unspecified). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events high fever, heart beat constantly over 115/min, muscle ache, arm pain, belly pain and red dots on skin were recovering at the time of this report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Rash macular
Clinical narrative: High fever; Heart beat constantly over 115/min; Muscle ache; Arm pain; Belly pain; Red dots on skin; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 06May2021 at 18:00 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history included dust allergy and allergy to oyster (seafood allergy). Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. On 06May2021 at 23:00, the patient experienced high fever, heart beat constantly over 115/min, muscle ache, arm pain, belly pain and red dots on skin. The events resulted in emergency room/department or urgent care. Therapeutic measures were taken as a result of the events (unspecified). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events high fever, heart beat constantly over 115/min, muscle ache, arm pain, belly pain and red dots on skin were recovering at the time of this report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Nausea
Clinical narrative: Moderately dizzy so had to lie down for half an hour or 45 minutes before it let up enough to drive. Dizziness persisted for a week, lessening each day; Mild nausea with it; This is a spontaneous report from a contactable consumer, the patient. A 68-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWO151) via an unspecified route of administration in the left arm on 09Apr2021 at 10:00 (at the age of 68-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism, arthritis, osteoporosis, gluten intolerance and known allergies to some fruits and cow dairy. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included ursodeoxycholic acid (URSODIOL), pancreatin (CREON) and levothyroxine sodium (LEVOTHYROXIN), all for unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 10:00, the patient experienced moderately dizzy so had to lie down for half an hour or 45 minutes before it let up enough to drive and experienced mild nausea with it. Dizziness persisted for a week and was lessening each day. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the events and included treatment with self prescribed meclizine (MECLOZINE) for 2 days. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events dizzy was resolved on 16Apr2021 and nausea was resolved on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Chills, Headache, Pain
Clinical narrative: Whole body aches severely/ Just sort of in pain; Body aches severely, especially my back; Bad headache; Chills overall; This is a spontaneous report from a contactable consumer, the patient. A 23-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 05May2021 at 08:15 (at the age of 23-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19, diagnosed prior to the vaccination, the patient. The patient had no known allergies. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. On 05May2021 at 18:00, the patient experienced whole body ache severely, especially back. The patient had bad headache, chills overall and just sort of in pain. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events whole body ache severely, especially back, headache, chills overall and just sort of in pain were not recovered at the time of this report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Heavy menstrual bleeding
Clinical narrative: After the first shot "I" received in April, menstrual cycle has been off. "My" cycle is very normal (5 days). After the first shot it has been 15 days.; This is a spontaneous report from a non-contactable consumer, the patient. A 45-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 08Apr2021 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient had no known allergies. Prior to the vaccination, the patient was diagnosed with COVID-19. Concomitant medications were not reported. On 20Apr2021, after the first shot the patient had received in Apr2021, her menstrual cycle had been off. Her cycle was very normal (5 days). After the first shot it had been 15 days. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event after the first shot she received in Apr2021, her menstrual cycle has been off, her cycle was very normal (5 days), after the first shot it had been 15 days was not resolved at the time of this report. The patient also received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 30Apr2021 (at the age of 45-years-old) as a single dose for COVID-19 immunisation.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Arthralgia, Fatigue, Headache, Joint stiffness
Clinical narrative: Intense hunger pains; Fatigue; Headache; Joint pain; Localized first finger joint stiffness and pain; Localized first finger joint stiffness and pain; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 05May2021 at 13:00 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other medications within 2 weeks prior to the vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 14Apr2021 at 13:00 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. On 06May2021 at 09:00, 2nd day, the patient experienced joint pain. On 07May2021, 3rd day, the patient experienced fatigue, headache and intense hunger pains. On an unknown date in May2021, the patient experienced localized first finger joint stiffness and pain. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the events joint pain on 2nd day, fatigue, headache, intense hunger pains on 3rd day, localized first finger joint stiffness and pain and treatment included Tylenol severe cold and flu. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events joint pain, intense hunger pains, fatigue, headache, localized first finger joint stiffness and pain were resolving at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: Intense hunger pains; Fatigue; Headache; Joint pain; Localized first finger joint stiffness and pain; Localized first finger joint stiffness and pain; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 05May2021 at 13:00 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other medications within 2 weeks prior to the vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 14Apr2021 at 13:00 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. On 06May2021 at 09:00, 2nd day, the patient experienced joint pain. On 07May2021, 3rd day, the patient experienced fatigue, headache and intense hunger pains. On an unknown date in May2021, the patient experienced localized first finger joint stiffness and pain. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the events joint pain on 2nd day, fatigue, headache, intense hunger pains on 3rd day, localized first finger joint stiffness and pain and treatment included Tylenol severe cold and flu. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events joint pain, intense hunger pains, fatigue, headache, localized first finger joint stiffness and pain were resolving at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Postmenopausal haemorrhage, SARS-CoV-2 test
Clinical narrative: I got a menstrual period 2 days after 2nd Pfizer dose. It had been 8 months since last period.; This is a spontaneous report from a non-contactable consumer.  A 50-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EW0153),  via an unspecified route of administration, in Arm Left on 12Apr2021 10:15  (at the age of 50-year-old ) as single dose for covid-19 immunisation.  The patient had received the first dose of bnt162b2 (lot number  EP7534) on 22Mar2021 at 10:15 AM in Left arm. The patient was not pregnant. No other vaccine was received in four weeks. The patient had not Covid prior vaccination. Medical history included Major depressive disorder. Other medications in two weeks included anti depressants. No known allergies. The patient had a negative Covid Nasal Swab test on 13Apr2021. The patient reported to get a menstrual period 2 days after 2nd dose of Pfizer vaccine on 14Apr2021. It had been 8 months since last period. No treatment was received. She was not Covid tested post vaccination. The outcome of the event was unknown.    No follow-up attempts are possible. No further information is expected.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Lymphadenopathy, Tinnitus
Clinical narrative: Ringing Ears; Swollen glands; Severe Headache; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration  in the left arm on 25Mar2021 at 18:30 (at the age of 58-years-old) and also received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on an unknown date in 2021 as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient's known allergies were reported as none. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications were reported as none. On 16Apr2021, the patient experienced ringing ears, swollen glands and severe headache. Therapeutic measures were not taken as a result of the reported events. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events ringing ears, swollen glands and severe headache were not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Fatigue, Headache, Myalgia
Clinical narrative: Severe fatigue; muscle pain; weakness; severe headache; This is a spontaneous report from a non-contactable nurse, the patient. A 45-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 26Apr2021 at 15:15 (at the age of 45-year-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient had no known allergies. Prior to the vaccination the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 05Apr2021 at 15:00 (at the age of 45-year-old), as a single dose for COVID-19 immunisation. On 27Apr2021 at 03:00, the patient experienced severe fatigue, muscle pain, weakness, and severe headache. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event severe fatigue, muscle pain, weakness, and severe headache was not resolved at the time of this report.   No follow-up attempts are possible, information about lot/batch number cannot be obtained. No further information is expected.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Eye movement disorder, Fatigue, Joint range of motion decreased, Muscle tightness, Pain
Clinical narrative: Upper torso muscles locking up to the point where  can't rotate neck, left arm, and eyes; Upper torso muscles locking up to the point where I can't rotate my neck, left arm, and eyes; Upper torso muscles locking up to the point where I can't rotate my neck, left arm, and eyes; Pain very severe; Extreme fatigue; This is a spontaneous report from a contactable healthcare professional, the patient. A 32-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0179) via an unspecified route of administration in the left arm on 07May2021 at 08:45 (at the age of 32-year-old), as a single dose for COVID-19 immunisation. Medical history included asthma, COVID-19, hysterectomy for endometriosis and known allergy to sulfa. Prior to the vaccination, the patient was diagnosed with COVID-19.  The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. Concomitant medications included sertraline (MANUFACTURER UNKNOWN) and estradiol (ESTROGEN) for unknown indications from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 15Apr2021 at 09:00 (at the age of 32-year-old), as a single dose for COVID-19 immunisation. On 08May2021 at 00:00, the patient experienced upper torso muscles locking up to the point where patient could not rotate neck, left arm and eyes, pain was very severe accompanied by extreme fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events upper torso muscles locking up to the point where patient can't rotate neck, left arm, and eyes and pain very severe, accompanied by extreme fatigue was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Fatigue, Headache, Pain, Pain in extremity
Clinical narrative: Fever up to 102 degrees; Headache; Pain in the left arm; Severe itchiness on the left side of the body (head to toe); Body aches; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP69SS) via an unspecified route of administration in the left arm on 29Apr2021 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications taken within two weeks of vaccination included VITAFOL, VITAMIN D3, VITAMIN B-12, and IRON, all for unknown indication from unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP69SS) via an unspecified route of administration in the left arm on 08Apr2021 at the age of 38-years-old as a single dose for COVID-19 immunisation. On 29Apr2021, the patient experienced fever up to 102 degrees (units unspecified), pain in the left arm, severe itchiness on the left side of the body from head to toe, body aches, and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of the events and included treatment with TYLENOL, every six hours. The clinical outcome of the events fever up to 102 degrees (units unspecified), pain in the left arm, severe itchiness on the left side of the body from head to toe, body aches, and fatigue was resolved on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Pyrexia
Clinical narrative: Fever up to 102 degrees; Headache; Pain in the left arm; Severe itchiness on the left side of the body (head to toe); Body aches; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP69SS) via an unspecified route of administration in the left arm on 29Apr2021 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications taken within two weeks of vaccination included VITAFOL, VITAMIN D3, VITAMIN B-12, and IRON, all for unknown indication from unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP69SS) via an unspecified route of administration in the left arm on 08Apr2021 at the age of 38-years-old as a single dose for COVID-19 immunisation. On 29Apr2021, the patient experienced fever up to 102 degrees (units unspecified), pain in the left arm, severe itchiness on the left side of the body from head to toe, body aches, and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of the events and included treatment with TYLENOL, every six hours. The clinical outcome of the events fever up to 102 degrees (units unspecified), pain in the left arm, severe itchiness on the left side of the body from head to toe, body aches, and fatigue was resolved on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). A 30-year-old (non-pregnant) female patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# unknown), at the age of 30, via an unspecified route of administration, in the left arm, on May 4, 2021, at 03:00, single dose, for COVID-19 immunisation. No medical history or concomitant medications reported. Prior to the vaccination, patient was not diagnosed with COVID-19. On May 5, 2021, patient experienced loss of taste. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures taken as a result of the event. Since the vaccination, patient has not tested for COVID-19. The outcome of loss of taste: not resolved (at the time of report). No follow-up attempts possible. Information about batch/lot number cannot be obtained. No further information expected.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Vaccination site pain
Clinical narrative: Pain in left arm around injections site; The pain intensifies as I lift my arm up or stretch.; This is a spontaneous report from a contactable consumer, the patient. A 65-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 30Mar2021 (at the age of 65-year-old), as a single dose for COVID-19 immunisation. Medical history included celiac disease, known allergy to nasal sprays and the patient was a breast cancer survivor. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications were not reported. The patient previously received ciprofloxacin (CIPRO) for unspecified indication from unknown date and experienced drug allergy and received first dose of BNT162b2 (COMIRNATY; Lot Number: EN6199) via an unspecified route of administration in the left arm on 08Mar2021, as a single dose for COVID-19 immunisation. On 30Mar2021, since the second vaccine was administered, the patient experienced pain in left arm around injection site. It had been over a month now (at the time of reporting). The pain intensified as the patient lifted the arm up or stretched. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event pain in left arm around injections site and pain intensified patient as lifted the arm up or stretched was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia, Urticaria
Clinical narrative: Hives on arms then followed to back and then under eyes; Light fever; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 21Apr2021 at 10:30 (at the age of 27-year-old) as a single dose for COVID-19 immunisation. The patient did not have medical history and known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medication within two weeks prior to the vaccination. On 26Apr2021, the patient experienced light fever. On the same day, the patient underwent a body temperature test and the result was 37.4 degrees Centigrade. On 05May2021 at 14:00, the patient experienced hives on arms then followed to back and then under eyes. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event light fever was resolved on an unknown date in 2021 while that of the event hives on arms then followed to back and then under eyes was resolved on 05May2021, after the duration of 3 hours.  No follow-up attempts are needed. No further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash appeared on the right arm 24 hours after the vaccine was administered; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 05May2021 at 15:15 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any concomitant medications. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 06May2021, 24 hours after the vaccine was administered, the patient experienced rash on the right arm. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event rash appeared on the right arm 24 hours after the vaccine was administered was resolved on an unknown date in May2021.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Pain, Pain in extremity
Clinical narrative: Mild breathing difficulty at night before bedtime for a short while; Sore arm, body aches were mild; Sore arm, body aches were mild; This is a spontaneous report from a contactable consumer, the patient. A 20-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 08May2021 at 08:15 (at the age of 20-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive other vaccines within four weeks prior to the vaccination. Concomitant medications included unspecified vitamins for unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in the left arm on 17Apr2021 at 15:15 (at the age of 20-years-old) as a single dose for COVID-19 immunisation. On 08May2021 at 21:45, the patient experienced mild breathing difficulty at night before bedtime for a short while around 21:45. Used essential oil to help breathing around 22:30 and the problem went away in the night. This morning (at the time of this report) woke at 07:00 and was totally fine. Took vitamins 3 hours after vaccine so all other side effects sore arm, body aches were mild. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the events that included unspecified vitamins and essential oil. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events mild breathing difficulty at night before bedtime for a short while, sore arm, body aches were mild was resolved on an unknown date in May2021.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pyrexia, SARS-CoV-2 test
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). A 22-year-old (non-pregnant) female patient received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# EW0170), at the age of 22, via an unspecified route of administration, on May 6, 2021, single dose, for COVID-19 immunisation. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received unspecified concomitant medication within two weeks prior to vaccination. The patient previously received amoxicillin on an unknown date and experienced drug allergy. Since the vaccination, patient has tested for COVID-19. On May 5, 2021, patient underwent a nasal swab test, SARS-CoV-2 test: negative. On May 6, 2021, patient experienced fever and chills for about 24 hours. Therapeutic measures taken as a result of events included Tylenol (paracetamol) from an unknown date and unknown if ongoing. The outcome of fever and chills for about 24 hours resolved on May 7, 2021. No follow-up attempts needed. No further information expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Chills, Dizziness, Fatigue
Clinical narrative: Injection site pain; Tiredness; Headache; Muscle pain; Chills; Joint pain; Nausea; Dizziness; Felt unwell; Swollen lymph nodes; Neck and back ache; Neck and back ache; This is a spontaneous report from a non-contactable consumer, the patient. A 51-year-old female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 16Apr2021 at 15:00 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. The medical history included allergy to sulfa drugs. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medications within two weeks of vaccination. On 16Apr2021 at 17:00, the patient experienced injection site pain, tiredness, headache, muscle pain, chills, joint pain, nausea, dizziness, felt unwell, swollen lymph nodes, neck and back ache. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events injection site pain, tiredness, headache, muscle pain, chills, joint pain, nausea, dizziness, felt unwell, swollen lymph nodes, neck and back ache were resolved on an unknown date in 2021. The patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0183) via an unspecified route of administration in the left arm on 07May2021 at 15:00 (at the age of 51-years-old) as a single dose for COVID-19 immunisation.   No follow-up attempts are possible. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Lymphadenopathy, Malaise, Myalgia, Nausea
Clinical narrative: Injection site pain; Tiredness; Headache; Muscle pain; Chills; Joint pain; Nausea; Dizziness; Felt unwell; Swollen lymph nodes; Neck and back ache; Neck and back ache; This is a spontaneous report from a non-contactable consumer, the patient. A 51-year-old female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 16Apr2021 at 15:00 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. The medical history included allergy to sulfa drugs. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medications within two weeks of vaccination. On 16Apr2021 at 17:00, the patient experienced injection site pain, tiredness, headache, muscle pain, chills, joint pain, nausea, dizziness, felt unwell, swollen lymph nodes, neck and back ache. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events injection site pain, tiredness, headache, muscle pain, chills, joint pain, nausea, dizziness, felt unwell, swollen lymph nodes, neck and back ache were resolved on an unknown date in 2021. The patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0183) via an unspecified route of administration in the left arm on 07May2021 at 15:00 (at the age of 51-years-old) as a single dose for COVID-19 immunisation.   No follow-up attempts are possible. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Neck pain, Vaccination site pain
Clinical narrative: Injection site pain; Tiredness; Headache; Muscle pain; Chills; Joint pain; Nausea; Dizziness; Felt unwell; Swollen lymph nodes; Neck and back ache; Neck and back ache; This is a spontaneous report from a non-contactable consumer, the patient. A 51-year-old female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 16Apr2021 at 15:00 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. The medical history included allergy to sulfa drugs. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medications within two weeks of vaccination. On 16Apr2021 at 17:00, the patient experienced injection site pain, tiredness, headache, muscle pain, chills, joint pain, nausea, dizziness, felt unwell, swollen lymph nodes, neck and back ache. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events injection site pain, tiredness, headache, muscle pain, chills, joint pain, nausea, dizziness, felt unwell, swollen lymph nodes, neck and back ache were resolved on an unknown date in 2021. The patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0183) via an unspecified route of administration in the left arm on 07May2021 at 15:00 (at the age of 51-years-old) as a single dose for COVID-19 immunisation.   No follow-up attempts are possible. No further information is expected.
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain upper, Diarrhoea, Pain in extremity
Clinical narrative: My stomach hasn't felt this tight; Ridiculous amount of diarrhea; My arm hurts a bit; This is a spontaneous report from a contactable consumer, the patient. A 22-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 08May2021 at 13:00 (at the age of 22-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive concomitant medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09May2021 at 00:00, the patient experienced diarrhea, his arm hurt and had stomach tightness. The day after first shot, on 09May2021 at 12:52, at the time of report, the patient was experiencing a ridiculous amount of diarrhea. It wouldn't stop. It could smell his fear. The patients arm hurt a bit but it was not too terrible. His stomach hadn't felt so tight since he ate an entire box of taco bell's party pack nachos with extra jalapenos. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events ridiculous amount of diarrhea, arm hurt a bit but it was not too terrible and stomach tightness was not resolved at the time of this report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Blister, Urticaria
Clinical narrative: Burning sensation in left abdomen; Hives; Blister; This is a spontaneous report from a contactable consumer, the patient. A 69-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unspecified date in 2021 as a single dose for COVID-19 immunisation. Medical history included breast cancer survivor and high blood pressure since unknown dates. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included omeprazole (MANUFACTURER UNKNOWN) and metoprolol tartrate (MANUFACTURER UNKNOWN); from an unknown start date, for an unknown indication and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6200 ) via an unspecified route of administration in the right arm on 16Feb2021 as a single dose for COVID-19 immunisation and also received hydrocodone (MANUFACTURER UNKNOWN) on an unknown date and experienced drug allergy. On 30Mar2021 at 21:00, the patient experienced burning sensation in left abdomen, hives and blister. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19.. The clinical outcome of the events burning sensation in left abdomen, hives and blister was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: Suspected COVID-19, Testicular pain
Clinical narrative: "I" had COVID in late March and it felt like "I" had it again for 24 hours.; "I" had testicular pain that came in separate occasions. One the night of and the second the day after. "My" testes felt pressure and it caused pain.; This is a spontaneous report from a contactable consumer, the patient. A 22-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 07May2021 at 14:30 (at the age of 22-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma and prior to the vaccination, the patient was diagnosed with COVID-19 in late Mar(unspecified year). The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included fexofenadine hydrochloride (ALLEGRA) for unknown indication from unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0153) via an unspecified route of administration in the left arm on 16Apr2021 at 17:30 (at the age of 22-years-old) as a single dose for COVID-19 immunisation. The patient had COVID-19 in late Mar(unspecified year). On 07May2021 at 22:30, the patient felt like having COVID-19 again for 24 hours. The patient experienced one weird event, testicular pain that happened in separate occasions. One the night of and the second the day after. The patient felt pressure in the testes and it caused pain. It resolved on its own within 24 hours. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events felt like having COVID-19 again for 24 hours, testicular pain, felt pressure in the testes and it caused pain were resolved on 08May2021 at 22:30.  No follow-up attempts are needed. No further information is expected.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Myalgia, Pain, Pyrexia
Clinical narrative: Severe body aches; Tiredness; Muscle aches; Slight fever; Headaches; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 08May2021 at 15:30 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included unspecified multivitamin, ethinylestradiol, levonorgestrel (VIENVA), pseudoephedrine hydrochloride (SUDAFED) and fexofenadine hydrochloride (ALLEGRA); all for an unknown indication from an unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 17Apr2021 at 15:00 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. On 08May2021 at 20:00, the patient experienced severe body aches, tiredness, muscle aches, slight fever and headaches. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events severe body aches, tiredness, muscle aches, slight fever and headaches were not resolved at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.